AR121515A1 - Composiciones y métodos para evaluar la eficacia de inhibidores de transportadores de neurotransmisores - Google Patents
Composiciones y métodos para evaluar la eficacia de inhibidores de transportadores de neurotransmisoresInfo
- Publication number
- AR121515A1 AR121515A1 ARP210100576A ARP210100576A AR121515A1 AR 121515 A1 AR121515 A1 AR 121515A1 AR P210100576 A ARP210100576 A AR P210100576A AR P210100576 A ARP210100576 A AR P210100576A AR 121515 A1 AR121515 A1 AR 121515A1
- Authority
- AR
- Argentina
- Prior art keywords
- efficacy
- methods
- evaluate
- compositions
- transporter inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062986603P | 2020-03-06 | 2020-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR121515A1 true AR121515A1 (es) | 2022-06-08 |
Family
ID=77613738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210100576A AR121515A1 (es) | 2020-03-06 | 2021-03-05 | Composiciones y métodos para evaluar la eficacia de inhibidores de transportadores de neurotransmisores |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12612661B2 (https=) |
| EP (1) | EP4106872A4 (https=) |
| JP (1) | JP2023515665A (https=) |
| KR (1) | KR20230005816A (https=) |
| CN (1) | CN115515680A (https=) |
| AR (1) | AR121515A1 (https=) |
| AU (1) | AU2021231683A1 (https=) |
| BR (1) | BR112022017770A2 (https=) |
| CA (1) | CA3174572A1 (https=) |
| IL (1) | IL296168A (https=) |
| MX (1) | MX2022010816A (https=) |
| TW (1) | TW202146660A (https=) |
| WO (1) | WO2021178166A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000019303A1 (it) * | 2020-08-05 | 2022-02-05 | Univ Degli Studi Di Brescia | Analoghi strutturali del metilfenidato come agenti disease-modifying della malattia di parkinson |
| CN114848835B (zh) * | 2022-03-22 | 2023-08-25 | 暨南大学 | 塞来昔布的聚乙二醇修饰及连接叶酸基团的靶向药物分子及制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6945457B1 (en) * | 1996-05-10 | 2005-09-20 | Transaction Holdings Ltd. L.L.C. | Automated transaction machine |
| JP4198582B2 (ja) * | 2003-12-02 | 2008-12-17 | 独立行政法人科学技術振興機構 | タンタルオキシナイトライド酸素還元電極触媒 |
| WO2007128884A1 (en) * | 2006-05-09 | 2007-11-15 | Oy Jurilab Ltd | Novel genes and markers in type 2 diabetes and obesity |
| US20080299125A1 (en) | 2006-06-05 | 2008-12-04 | Perlegen Sciences, Inc. | Genetic basis of treatment response in depression patients |
| WO2008065544A2 (en) | 2006-09-11 | 2008-06-05 | Mcgill University | Genetic predictors of risk for type 2 diabetes mellitus |
| EP2243834A1 (en) | 2007-03-05 | 2010-10-27 | Cancer Care Ontario | Assessment of risk for colorectal cancer |
| US20170029892A1 (en) | 2009-05-29 | 2017-02-02 | Jay L. Lombard | Methods and compositions for the treatment of post-traumatic stress disorder |
| US8355927B2 (en) * | 2010-11-05 | 2013-01-15 | Genomind, Llc | Neuropsychiatric test reports |
| EP2707498B1 (en) | 2011-01-31 | 2018-01-17 | Denovo Biomarkers Inc. | Method for discovering pharmacogenomic biomarkers |
| WO2012156515A1 (en) * | 2011-05-18 | 2012-11-22 | Rheinische Friedrich-Wilhelms-Universität Bonn | Molecular analysis of acute myeloid leukemia |
| CA2838207A1 (en) | 2011-06-08 | 2012-12-13 | Denovo Biopharma (Hangzhou) Ltd. Co. | Methods and compositions of predicting activity of retinoid x receptor modulator |
| US20140274764A1 (en) | 2013-03-15 | 2014-09-18 | Pathway Genomics Corporation | Method and system to predict response to treatments for mental disorders |
| US20170253928A1 (en) | 2013-03-15 | 2017-09-07 | Pathway Genomics Corporation | Method and system to predict response to treatments for mental disorders |
| TR201907106T4 (tr) | 2014-03-14 | 2019-06-21 | Caredx Inc | Bir transplant alıcısında immünosüpresif terapileri izleme yöntemleri. |
-
2021
- 2021-02-23 CA CA3174572A patent/CA3174572A1/en active Pending
- 2021-02-23 KR KR1020227034374A patent/KR20230005816A/ko active Pending
- 2021-02-23 EP EP21764344.4A patent/EP4106872A4/en active Pending
- 2021-02-23 BR BR112022017770A patent/BR112022017770A2/pt unknown
- 2021-02-23 AU AU2021231683A patent/AU2021231683A1/en active Pending
- 2021-02-23 JP JP2022552541A patent/JP2023515665A/ja active Pending
- 2021-02-23 WO PCT/US2021/019265 patent/WO2021178166A1/en not_active Ceased
- 2021-02-23 IL IL296168A patent/IL296168A/en unknown
- 2021-02-23 US US17/905,511 patent/US12612661B2/en active Active
- 2021-02-23 MX MX2022010816A patent/MX2022010816A/es unknown
- 2021-02-23 CN CN202180031602.1A patent/CN115515680A/zh active Pending
- 2021-03-05 AR ARP210100576A patent/AR121515A1/es unknown
- 2021-03-05 TW TW110107927A patent/TW202146660A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US12612661B2 (en) | 2026-04-28 |
| CN115515680A (zh) | 2022-12-23 |
| WO2021178166A1 (en) | 2021-09-10 |
| CA3174572A1 (en) | 2021-09-10 |
| US20230193388A1 (en) | 2023-06-22 |
| MX2022010816A (es) | 2022-12-13 |
| BR112022017770A2 (pt) | 2022-11-29 |
| JP2023515665A (ja) | 2023-04-13 |
| TW202146660A (zh) | 2021-12-16 |
| EP4106872A4 (en) | 2024-04-10 |
| EP4106872A1 (en) | 2022-12-28 |
| KR20230005816A (ko) | 2023-01-10 |
| IL296168A (en) | 2022-11-01 |
| AU2021231683A1 (en) | 2022-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP22051489A (es) | Compuestos inhibidores de metaloenzimas | |
| AR119676A1 (es) | Receptores de antígenos quiméricos de gprc5d y células que los expresan | |
| CL2019000973A1 (es) | Método y sistemas para la indexación de datos bioinformáticos. | |
| MX2021014443A (es) | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. | |
| CO2022013827A2 (es) | Compuestos y métodos para modular el empalme | |
| AR117918A1 (es) | COMPLEJOS-ESPECÍFICOS LTBP INHIBIDORES DE TGFb Y SUS USOS | |
| CO2019004630A2 (es) | Composiciones de células t con car anti-bcma | |
| MX2020002542A (es) | Variantes de interleucina-18 y metodos de uso. | |
| UY37134A (es) | Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4 | |
| MX2020012561A (es) | Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiazepinona e inmunoterapeuticos y metodos de uso de las mismas. | |
| CO2022015925A2 (es) | Compuestos y métodos para modular el corte y empalme | |
| AR121515A1 (es) | Composiciones y métodos para evaluar la eficacia de inhibidores de transportadores de neurotransmisores | |
| GT201000088A (es) | 2 -fluoro-2´desoxitetrahidrouridinas como inhibidores de citidina desaminasa | |
| CL2022002779A1 (es) | Compuestos y métodos para modular el proceso de corte y empalme | |
| MX2016013239A (es) | Tratamiento de cancer utilizando receptor quimerico de antigeno anti-cd19. | |
| CR20120303A (es) | Tratamientos para trastornos gastrointestinales | |
| BR112018002503A2 (pt) | comutador em cascata entre pluralidades de lnas | |
| MX2018003301A (es) | Inhibidores de pcna. | |
| CO2023015915A2 (es) | Anticuerpos anti-ccr8 | |
| CL2022003703A1 (es) | Compuestos antibióticos, métodos de fabricación de los mismos, composiciones farmacéuticas conteniendo los mismos y usos | |
| MX2021004925A (es) | Variantes de adn-polimerasa modificadas. | |
| MX383670B (es) | Nuevos marcadores de la diferenciación de th17 para el acné y usos de los mismos. | |
| CO2022000705A2 (es) | Receptor de antígeno quimérico (car) anti-hk2 | |
| CO2019002608A2 (es) | Biomarcadores de arn para angioedema hereditario | |
| MX2024007360A (es) | Composiciones que comprenden compuestos de bisfluoroalquil-1,4-ben zodiacepinona y metodos de uso de las mismas. |